Peter Ashley Marks
Director · ALTERITY THERAPEUTICS LTD
IndividualBuying only
- 2026
- Sep 8, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter Ashley Marks files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Allen Stamler - $24K in ATHE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter Ashley Marks?
Peter Ashley Marks is a corporate insider, tracked as Director of ALTERITY THERAPEUTICS LTD (ATHE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter Ashley Marks submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peter Ashley Marks been buying or selling stock?
Recorded transactions: 2 open-market purchases ($48K) and 0 open-market sales across all tracked filings.
